Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 3
2002 1
2003 2
2005 3
2006 1
2008 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Autoantibodies frequently detected in patients with aplastic anemia.
Hirano N, Butler MO, Von Bergwelt-Baildon MS, Maecker B, Schultze JL, O'Connor KC, Schur PH, Kojima S, Guinan EC, Nadler LM. Hirano N, et al. Blood. 2003 Dec 15;102(13):4567-75. doi: 10.1182/blood-2002-11-3409. Epub 2003 Aug 28. Blood. 2003. PMID: 12947009
Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1.
Maecker B, von Bergwelt-Baildon MS, Sherr DH, Nadler LM, Schultze JL. Maecker B, et al. Int J Cancer. 2005 Jun 10;115(2):333-6. doi: 10.1002/ijc.20906. Int J Cancer. 2005. PMID: 15688394 Free article.
Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.
Kondo E, Maecker B, Weihrauch MR, Wickenhauser C, Zeng W, Nadler LM, Schultze JL, von Bergwelt-Baildon MS. Kondo E, et al. Clin Cancer Res. 2008 Oct 15;14(20):6574-9. doi: 10.1158/1078-0432.CCR-08-0825. Clin Cancer Res. 2008. PMID: 18927298 Free article.
CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.
von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S, Draube A, Maecker B, Menezes I, Nadler LM, Schultze JL. von Bergwelt-Baildon M, et al. Blood. 2006 Apr 1;107(7):2786-9. doi: 10.1182/blood-2004-01-0113. Epub 2005 Dec 15. Blood. 2006. PMID: 16357329 Free PMC article.
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.
Vonderheide RH, Schultze JL, Anderson KS, Maecker B, Butler MO, Xia Z, Kuroda MJ, von Bergwelt-Baildon MS, Bedor MM, Hoar KM, Schnipper DR, Brooks MW, Letvin NL, Stephans KF, Wucherpfennig KW, Hahn WC, Nadler LM. Vonderheide RH, et al. Cancer Res. 2001 Dec 1;61(23):8366-70. Cancer Res. 2001. PMID: 11731409 Free article.
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM. Vonderheide RH, et al. Clin Cancer Res. 2001 Nov;7(11):3343-8. Clin Cancer Res. 2001. PMID: 11705846 Free article.
Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients.
Maecker B, von Bergwelt-Baildon MS, Anderson KS, Vonderheide RH, Anderson KC, Nadler LM, Schultze JL. Maecker B, et al. Clin Exp Immunol. 2005 Sep;141(3):558-62. doi: 10.1111/j.1365-2249.2005.02879.x. Clin Exp Immunol. 2005. PMID: 16045747 Free PMC article.
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.
Trojan A, Schultze JL, Witzens M, Vonderheide RH, Ladetto M, Donovan JW, Gribben JG. Trojan A, et al. Nat Med. 2000 Jun;6(6):667-72. doi: 10.1038/76243. Nat Med. 2000. PMID: 10835683
Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application.
von Bergwelt-Baildon MS, Vonderheide RH, Maecker B, Hirano N, Anderson KS, Butler MO, Xia Z, Zeng WY, Wucherpfennig KW, Nadler LM, Schultze JL. von Bergwelt-Baildon MS, et al. Blood. 2002 May 1;99(9):3319-25. doi: 10.1182/blood.v99.9.3319. Blood. 2002. PMID: 11964299
CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
Vonderheide RH, Butler MO, Liu JF, Battle TE, Hirano N, Gribben JG, Frank DA, Schultze JL, Nadler LM. Vonderheide RH, et al. Int J Oncol. 2001 Oct;19(4):791-8. doi: 10.3892/ijo.19.4.791. Int J Oncol. 2001. PMID: 11562757
12 results
Jump to page
Feedback